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 Abstract   
Objective: Local anesthetics are able to inhibit inflammatory phenomena. The influence of bupivacaine broadly 
applied in obstetrical anesthesia on the reactive oxygen species (ROS) production is a matter of controversy. 
The study was aimed at elucidation of the influence of racemic bupivacaine on the opsonized zymosan (OZ) 
stimulated-peripheral blood chemiluminescence (CL) in laboring women, reflecting the reactive oxygen species 
(ROS) production associated with phagocytosis.
Material and methods: Blood samples drawn from 8 healthy parturients in active spontaneous labor and from 5 
healthy non-pregnant controls were incubated with the 0.3, 30, and 3000 μM bupivacaine concentrations and then 
luminol-dependent OZ-stimulated whole blood CL was assessed. 
Results: Bupivacaine depressed CL; however, the inhibitory effect was significant only at the highest, clinically 
irrelevant concentration (3000μM), in parturients being comparable to that observed in non-pregnant women. 
Conclusions: Bupivacaine at clinically relevant concentrations does not influence ROS production accompanying 
phagocytosis in peripheral blood of laboring women. The effect is comparable in parturients and non-pregnant 
controls. 
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Introduction
Parturition	 is	 physiologically	 characterized	 by	 upregulated	
both	 local	 and	 systemic	 inflammatory	 processes,	 involving	 a	
redox	 balance	 shift	 towards	 increased	 oxidative	 stress-related	
phenomena	 and	 leukocyte	 priming	 [1,	 2,	 3].	 Peripheral	 blood	




Local	 anesthetics	 (LA)	 which	 penetrate	 to	 systemic	
circulation	 during	 neuraxial	 analgesia	 or	 anesthesia	 are	 able	
to	 exert	 anti-inflammatory	 and	 immunosuppressive	 effects	 by	
mechanisms	 involving	 ion	 channel	 modulation	 (but	 not	 Na+ 
influx)	and	inhibition	of	Gq	proteins	of	 inflammatory	cells,	 i.e.	
phagocytes	 [4].	 Among	 other	 functions,	 the	 compounds	 are	
also	 able	 to	 inhibit	 phagocytosis	 and	 concomitant	 respiratory	
burst	with	 the	 increased	production	of	 reactive	oxygen	 species	
(ROS),	serving	the	oxygen-dependent	pathogen	degradation	and	




available	 data	 on	 the	 inhibition	 of	 ROS	 production	 and	
phagocytosis	are	conflicting	[6-14].	Whether	LA	administered	to	
laboring	women	would	significantly	modulate	the	inflammatory	
cell	 properties,	 i.e.	 phagocytosis	 and	 respiratory	 burst,	 which	




of	 racemic	 bupivacaine	 on	 ROS	 production	 connected	 with	
phagocytosis	 by	 peripheral	 blood	 phagocytes	 as	 measured	





1,4-phthalazine-dione),	 and	 zymosan	 A	 were	 purchased	 from	
Sigma,	 calf	 serum	 and	 phosphate	 buffered	 saline	 (PBS)	 were	
obtained	from	Biomed,	Lublin.






Samples	were	kept	 at	 37oC	 in	 thermoblock	TB	951U	 (JW	
Electronic,	Poland).
Study groups and blood sampling
The	 study	 has	 been	 approved	 by	 the	 University	 Ethics	
Comission.	 After	 obtaining	 informed	 consent	 peripheral	 vein	
blood	samples	were	drawn	from	8	healthy	parturients	 in	active	




Blood	 was	 sampled	 into	 2.7	 ml-EDTA	 tubes	 (Monovette,	
Sarstedt).	
Luminol-dependent whole blood chemiluminescence (CL) 
according to Slavikova et al. [16] 
200	µl	samples	of	anticoagulated	whole	blood	were	incubated	
with	 100	µl	 of	 different	 concentrations	 of	 bupivacaine	 in	PBS	
or	 PBS	 alone	 (control	 samples)	 at	 37oC	 for	 10	 minutes.	 End	







 Streszczenie   
Cel pracy: Anestetyki lokalne mają zdolność hamowania procesów zapalenia. Wpływ bupiwakainy, anestetyku 
szeroko stosowanego w anestezjologii położniczej, na produkcję reaktywnych form tlenu (RFT) jest przedmiotem 
kontrowersji. Celem pracy była ocena wpływu racemicznej bupiwakainy na chemiluminescencję (CL) krwi obwodowej 
kobiet rodzących stymulowaną opsonizowanym zymosanem (OZ), odzwierciedlającą produkcję reaktywnych form 
tlenu (RFT) towarzyszącą procesowi fagocytozy. 
Materiał i metody: Krew pełna pobrana od zdrowych 8 rodzących i 5 kobiet nieciężarnych była inkubowana z 
bupiwakainą w stężeniach 0,3; 30; i 3000 μM, a następnie oceniano zależną od luminolu chemiluminescencję (CL) 
krwi pełnej stymulowanej OZ. 
Wyniki: Bupiwakaina hamowała CL, jednak istotny efekt obserwowano dopiero przy zastosowaniu najwyższego 
badanego stężenia (3000μM). Efekt ten był porównywalny u rodzących i kobiet nieciężarnych.
Wniosek: Bupiwakaina w stężeniach istotnych klinicznie nie wpływa na produkcję RFT towarzyszącą procesowi 
fagocytozy przez komórki krwi obwodowej kobiet rodzących. Efekt ten jest porównywalny u rodzących i kobiet 
nieciężarnych.
 Słowa kluczowe: poród / bupiwakaina / chemiluminescencja / 
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were	 assessed	 by	 Friedman	 test,	 data	 between	 groups	 were	












The	 net	 CL	 values,	 regarding	 both	 intact	 and	 OZ-
stimulated	 whole	 blood,	 were	 slightly,	 insignificantly	 higher	
in	laboring	women	(Figure1,	2).	In	order	to	avoid	a	bias	in	CL	
estimations	due	to	an	increased	peripheral	blood	leukocyte	and	
polymorphonuclear	 cell	 count	 in	 parturients	 (Table	 I)	 we	 also	











stimulated	whole	 blood	CL	 reflecting	 phagocytosis	 only	 at	 the	
highest	applied,	clinically	irrelevant	concentration	(3000µM),	in	
parturients	being	comparable	to	that	observed	in	healthy	young	
women	 (Figure	 2,	 Table	 I).	 Bupivacaine	 did	 not	 significantly	
modify	 unstimulated	whole	 blood	 CL;	 however,	 in	 parturients	
the	values	obtained	by	the	bupivacaine	concentration	of	3000µM	
appeared	to	be	higher	than	in	non-pregnant	controls.	The	net	CL	
values,	 regarding	 both	 intact	 and	 OZ-stimulated	 whole	 blood,	
were	slightly,	 insignificantly	higher	 in	 laboring	women	(Figure	




in	 CL	 estimations	 connected	 with	 leukocytosis	 in	 parturients	




II).	 This	 would	 indicate	 that	 the	 influence	 of	 bupivacaine	 at	
















binding	 and	 indirect	 interactions	 effect,	 should	 be	 taken	 into	




in	 healthy	 donors	 the	 inhibitory	 effect	 of	 bupivacaine	 on	 the	




inhibition	 by	 LA	 was	 suggested	 to	 be	 associated	 with	 their	
physicochemical	 properties,	 specifically	 lipid	 solubility	 [7]	
and	 to	 be	 time-dependent	 [13].	 Interestingly,	 the	 enantiomer-
specific	 effects	 of	 bupivacaine	 concerning	 its	 influence	 on	
the	 ROS	 production	 were	 also	 noted,	 the	 S-(-)	 enantiomer	
displaying	 significantly	 less	 inhibition	 [8].	 On	 the	 other	 hand,	
S-(-)	bupivacaine	appeared	 to	be	more	effective	 in	suppressing	
the	neutrophil	priming	[9].	Other	authors	denied	any	significant	
influence	 of	 bupivacaine	 on	 cellular	 oxidative	 phenomena,	
chemotaxis,	 phagocytosis,	 intracellular	 calcium	 concentration	
and	protein	kinase	 activity	 and	 also	neglected	 its	 effect	 on	 the	
ROS	 production	 in	 a	 non-cellular	 setting	 (xanthine-xanthine	
oxidase)	[11,	12,	14].	
Table  I .  Peripheral blood leukocyte and polymorphonuclear cell (PMN) counts in 




[10 9 L-1] % PMN
Parturients 
(n=8) 9.7 ± 1.4
# 7.7 ± 1.2# 79.8 ± 3.3o
Non-Pregnant 
(n=5) 5.3 ± 1.4 3.5 ± 1.5 63.8 ± 15.0
Part. vs. Non-Pregn. U Mann-Whitney, # - denotes P=0.002; o - denotes 
P=0.019
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It	 should	be	stressed	 that	our	and	previously	 reported	data	
describe	 inhibitory	 effects	 of	 bupivacaine	on	phagocytosis	 and	
the	ROS	production	at	high,	clinically	irrelevant	concentrations.	
The	 half	 maximal	 inhibitory	 concentration	 (IC
50
)	 reflecting	 an	
inhibitory	 potential	 of	 bupivacaine	 on	 the	 ROS	 production	 in	
isolated	 phorbol	 ester-stimulated	 neutrophils	 was	 estimated	
to	 be	 of	 1.62	 ±	 0.05	 mM	 [7].	 Kiefer	 et	 al.	 investigating	 the	
influence	 of	 bupivacaine	 on	 the	 neutrophil	 respiratory	 burst	
accompanying	phagocytosis	could	observe	a	relevant	inhibition	
at	the	concentration	of	770	µM.	Interestingly,	other	amide	local	
anesthetic,	 lidocaine,	 also	 occasionally	 applied	 in	 obstetric	
anesthesia	was	shown	to	be	able	 to	block	OZ	stimulated	blood	
neutrophils	already	in	therapeutic	doses	[21],	whereas	ropivacaine,	




Bupivacaine	 suppresses	 CL	 of	 zymosan	 stimulated	 whole	
blood	of	healthy	parturients	in	a	concentration-dependent	manner,	
comparably	to	non-pregnant	women.	The	effect	is	less	expressed	
but	more	 significant	 in	 laboring	women,	however	negligible	at	
clinically	relevant	concentrations	in	both	groups.	
Table  I I .  The influence of bupivacaine on OZ stimulated whole blood CL response 




0 0.3 30 3000
Parturients 
(n=8) 100 93.91± 130.81 91.62 ± 110.46 0.64 ± 2.23***,*
Non-Pregnant 
(n=5) 100 81.07 ± 31.22 69.69 ± 29.80 0.01 ± 0.04**
Parturients: *** P< 0.001: 0-3000 µM bupivacaine, * P< 0.05: 0.3 – 3000 and 
30 -3000 µM bupivacaine
Non-Pregnant: ** P < 0.01: 0-3000 i 0.3 -3000 µM bupivacaine




0 0.3 30 3000
Parturients  
(n=8) 1.87 ± 0.24 2.43 ± 0.28 1.18 ± 0.23 0.15 ± 0.01°
Non-Pregnant 
(n=5) 1.23 ± 0.37 1.05 ± 0.26 0.98 ± 0.27 0.04 ± 0.01
° - denotes Part. vs. Non-Pregn., U Mann-Whitney, P=0.034. In either group 




0 0.3 30 3000
Parturients 
(n=8) 56.22 ± 4.59 48.27 ± 5.40 41.17 ± 4.64 0.14 ± 0.01∗∗
Non-Pregnant 
(n=5) 39.00 ± 5.67 36.48 ± 6.24 31.18 ± 5.02 0.04 ± 0.01∗
∗∗ - denotes 0 vs. 3000 µM bupivacaine, Friedman, P=0.0001,  
∗ - denotes 0 vs. 3000 µM bupivacaine, Friedman, P=0.014. Between the 
groups no differences could be found
Figure 1. Whole blood chemiluminescence (CL) of parturients and non-pregnant 
women [Vs]; intact blood incubated with increasing bupivacaine concentrations; M ± 
SEM.
Figure 2. Whole blood chemiluminescence (CL) of parturients and non-
pregnant women [Vs]; OZ stimulated blood incubated with increasing bupivacaine 
concentrations; M ± SEM.
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